title: Acalabrutinib for relapsed chronic lymphocytic leukaemia.
authors.forename: Talha Khan
authors.initials: TK
authors.lastname: Burki
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence; D019233:Retreatment
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D011719:Pyrazines; C000604908:acalabrutinib